speb/financial-data huggingface dataset:
Financial ratios for CARR — annual report dated 2024-12-31
Total revenue: 22486000000
Gross profit: 5981000000
Operating income: 2098000000
Net income: 5708000000
Capital expenditures: 519000000
Operating cash flow: 563000000
Depreciation & amortization: 1232000000
Net tangible assets: -6952000000
Owner earnings: 6421000000
Return on net tangible assets (%): -92.36191024165707
Capex to operating income (%): 24.737845567206865
Buffett classification: The Great
Stock price: 67.05
P/E ratio: 9.756555249150315
Shares outstanding: 830580423
Book value: 14395000000
P/B ratio: 3.868733404803751
Market cap (USD): 55690417362.149994
Debt to equity: 0.8887808266759292
Current ratio: 1.253294475418145
Quick ratio: 0.9619868220983274
Effective tax rate (%): 46.701846965699204
Interest coverage ratio: 3.617241379310345
COGS to revenue (%): 73.40122743040114
R&D to revenue (%): 3.050787156452904
SG&A to revenue (%): 14.217735479854133
Free cash flow (dilution-adjusted): -42000000
Buyback yield (%): 3.490726218405467
Retained earnings: 11483000000
Inventory turnover: 7.179208351457155
Receivables turnover: 8.482082233119577
Capitalized R&D asset: 1153590000
ROCI (R&D-adjusted, %): 7.345062605869941
Rosenberg metric: 1.6612576064908722
FCF margin (%): -0.18678288712976962
Revenue growth (%): 18.653369215344835
Rule of 40 score: 18.466586328215065
Financial ratios for CARR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 67.05
Shares outstanding: 830580423
Market cap (USD): 55690417362.149994
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CARR — quarterly report dated 2025-03-31
Total revenue: 5218000000
Gross profit: 1445000000
Operating income: 563000000
Net income: 437000000
Capital expenditures: 63000000
Operating cash flow: 483000000
Depreciation & amortization: 303000000
Net tangible assets: -7580000000
Owner earnings: 677000000
Return on net tangible assets (%): -8.931398416886543
Capex to operating income (%): 11.190053285968029
Buffett classification: The Great
Stock price: 62.28
P/E ratio: 29.59299127256293
Shares outstanding: 830580423
Book value: 14198000000
P/B ratio: 3.6433686959036486
Market cap (USD): 51728548744.44
Debt to equity: 0.8184955627553177
Current ratio: 1.2043930965625447
Quick ratio: 0.8267008985879333
Effective tax rate (%): 20.255474452554743
Interest coverage ratio: 5.026785714285714
COGS to revenue (%): 72.30739747029513
R&D to revenue (%): 2.932157914909927
SG&A to revenue (%): 13.970870065159065
Free cash flow (dilution-adjusted): 397000000
Buyback yield (%): 2.4899210035124746
Retained earnings: 11895000000
Inventory turnover: 1.4248489425981874
Receivables turnover: 1.7515944947969118
Capitalized R&D asset: 153000000
ROCI (R&D-adjusted, %): 2.247456825171516
FCF margin (%): 7.608279034112687
Rule of 40 score: 7.608279034112687
Financial ratios for CARR — quarterly report dated 2025-06-30
Total revenue: 6113000000
Gross profit: 1769000000
Operating income: 795000000
Net income: 633000000
Capital expenditures: 81000000
Operating cash flow: 649000000
Depreciation & amortization: 317000000
Net tangible assets: -7736000000
Owner earnings: 869000000
Return on net tangible assets (%): -11.233195449844882
Capex to operating income (%): 10.18867924528302
Buffett classification: The Great
Stock price: 72.13
P/E ratio: 55.990435430831766
Shares outstanding: 830580423
Book value: 15014000000
P/B ratio: 3.990260151258159
Market cap (USD): 59909765910.99
Debt to equity: 0.7917277207939256
Current ratio: 1.1663047643377187
Quick ratio: 0.7974198492783242
Effective tax rate (%): 19.950738916256157
Interest coverage ratio: 6.913043478260869
COGS to revenue (%): 71.06167184688368
R&D to revenue (%): 2.6337313921151644
SG&A to revenue (%): 13.299525601177816
Free cash flow (dilution-adjusted): 547000000
Buyback yield (%): 0.5675201610788293
Retained earnings: 12294000000
Inventory turnover: 1.5041551246537397
Receivables turnover: 1.8123332345093388
Capitalized R&D asset: 263510000
ROCI (R&D-adjusted, %): 2.752673375041616
Rosenberg metric: 2.1176470588235294
FCF margin (%): 8.94814330116146
Revenue growth (%): 17.152165580682254
Rule of 40 score: 26.100308881843716
Financial ratios for CARR — quarterly report dated 2025-09-30
Total revenue: 5579000000
Gross profit: 1449000000
Operating income: 495000000
Net income: 455000000
Capital expenditures: 117000000
Operating cash flow: 341000000
Depreciation & amortization: 325000000
Net tangible assets: -7731000000
Owner earnings: 663000000
Return on net tangible assets (%): -8.575863407062476
Capex to operating income (%): 23.636363636363637
Buffett classification: The Great
Stock price: 59.01
P/E ratio: 32.13937754834754
Shares outstanding: 830580423
Book value: 14839000000
P/B ratio: 3.302955102178718
Market cap (USD): 49012550761.229996
Debt to equity: 0.8315924253655906
Current ratio: 1.1409577901123016
Quick ratio: 0.7531947850780948
Effective tax rate (%): -0.23094688221709006
Interest coverage ratio: 4.267241379310345
COGS to revenue (%): 74.0276035131744
R&D to revenue (%): 2.706578239827926
SG&A to revenue (%): 14.393260440939237
Free cash flow (dilution-adjusted): 213000000
Buyback yield (%): 1.6016305778987372
Retained earnings: 12530000000
Inventory turnover: 1.3748335552596538
Receivables turnover: 1.7829977628635347
Capitalized R&D asset: 309360000
ROCI (R&D-adjusted, %): 1.6025138906295693
Rosenberg metric: -1.9875776397515528
FCF margin (%): 3.81788851048575
Revenue growth (%): -8.735481760183216
Rule of 40 score: -4.917593249697466
Financial ratios for CARR — annual report dated 2025-12-31
Total revenue: 21747000000
Gross profit: 5624000000
Operating income: 1907000000
Net income: 1587000000
Capital expenditures: 392000000
Operating cash flow: 2513000000
Depreciation & amortization: 1274000000
Net tangible assets: -8023000000
Owner earnings: 2469000000
Return on net tangible assets (%): -30.77402467904774
Capex to operating income (%): 20.5558468799161
Buffett classification: The Great
Stock price: 52.43
P/E ratio: 27.440032500245746
Shares outstanding: 830580423
Book value: 14128000000
P/B ratio: 3.0823422691031994
Market cap (USD): 43547331577.89
Debt to equity: 0.867143261608154
Current ratio: 1.1994658420016868
Quick ratio: 0.8504357604723082
Effective tax rate (%): 13.348164627363737
Interest coverage ratio: 4.163755458515284
COGS to revenue (%): 74.1389616958661
R&D to revenue (%): 2.8739596266151652
SG&A to revenue (%): 14.218053064790546
Free cash flow (dilution-adjusted): 2047000000
Buyback yield (%): 6.641049853599609
Retained earnings: 12193000000
Inventory turnover: 6.49335481272654
Receivables turnover: 8.240621447517999
Capitalized R&D asset: 1247310000
ROCI (R&D-adjusted, %): 6.163673847580816
Rosenberg metric: -0.5204081632653061
FCF margin (%): 9.412792569089989
Revenue growth (%): -3.2864893711642797
Rule of 40 score: 6.12630319792571
Financial ratios for CARR — quarterly report dated 2025-12-31
Total revenue: 4837000000
Gross profit: 961000000
Operating income: 54000000
Net income: 62000000
Capital expenditures: 131000000
Operating cash flow: 1040000000
Depreciation & amortization: 329000000
Net tangible assets: -8023000000
Owner earnings: 260000000
Return on net tangible assets (%): -3.2406830362707217
Capex to operating income (%): 242.5925925925926
Buffett classification: The Gruesome
Stock price: 52.43
P/E ratio: 27.440032500245746
Shares outstanding: 830580423
Book value: 14128000000
P/B ratio: 3.0823422691031994
Market cap (USD): 43547331577.89
Debt to equity: 0.867143261608154
Current ratio: 1.1994658420016868
Quick ratio: 0.8504357604723082
Effective tax rate (%): -640
Interest coverage ratio: 0.46956521739130436
COGS to revenue (%): 80.13231341740749
R&D to revenue (%): 3.3078354351870995
SG&A to revenue (%): 15.443456688029771
Free cash flow (dilution-adjusted): 890000000
Buyback yield (%): 1.0999525864018715
Retained earnings: 12193000000
Inventory turnover: 1.5610149013290375
Receivables turnover: 1.83289124668435
Capitalized R&D asset: 314300000
ROCI (R&D-adjusted, %): 0.1864630051913494
Rosenberg metric: -3.2317880794701987
FCF margin (%): 18.39983460822824
Revenue growth (%): -13.29987452948557
Rule of 40 score: 5.09996007874267
Financial ratios for CINH.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 331912754
Market cap (USD): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CINH.L — annual report dated 2022-12-31
Total revenue: 0
Operating income: -2132530.120481928
Net income: -2972289.1566265062
Capital expenditures: 1022891.5662650603
Operating cash flow: -2398795.180722892
Net tangible assets: -1208433.7349397591
Owner earnings: -3995180.7228915663
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 331912754
Book value: -938554.2168674697
Market cap (USD): 0
Debt to equity: -3.089858793324776
Current ratio: 0.4014705882352941
Quick ratio: 0.4014705882352941
Interest coverage ratio: -18.247422680412374
Free cash flow (dilution-adjusted): -3421686.746987952
Retained earnings: -19602409.63855422
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CINH.L — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -73417.72151898734
Operating income: -1777215.1898734176
Net income: -4743037.974683544
Capital expenditures: 1651898.734177215
Operating cash flow: -2553164.5569620254
Depreciation & amortization: 0
Net tangible assets: -6264556.962025316
Owner earnings: -6394936.708860759
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 331912754
Book value: -6218987.341772152
Market cap (USD): 0
Debt to equity: -1.5605536332179928
Current ratio: 0.14667472793228536
Quick ratio: 0.14667472793228536
Interest coverage ratio: -5.014285714285714
Free cash flow (dilution-adjusted): -4205063.29113924
Retained earnings: -37883544.30379747
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CINH.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -15735000
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 331912754
Book value: 5596250
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 3.4721911994639267
Current ratio: 0.4922360248447205
Quick ratio: 0.4078674948240166
Retained earnings: -51420000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CINH.L — annual report dated 2024-12-31
Total revenue: 106250
Gross profit: 100000
Operating income: -6057500
Net income: -13733750
Capital expenditures: 4527500
Operating cash flow: -1716250
Depreciation & amortization: 116250
Net tangible assets: -15735000
Owner earnings: -18145000
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 331912754
Book value: 5596250
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 3.4721911994639267
Current ratio: 0.4922360248447205
Quick ratio: 0.4078674948240166
Interest coverage ratio: -4.315227070347284
COGS to revenue (%): 5.88235294117647
SG&A to revenue (%): 5685.882352941177
Free cash flow (dilution-adjusted): -8055000
Retained earnings: -51420000
Inventory turnover: 0.03067484662576687
Receivables turnover: 0.8095238095238095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.70180446528698
FCF margin (%): -7581.176470588235
Rule of 40 score: -7581.176470588235
Financial ratios for CINH.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -17973972.602739725
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 331912754
Book value: 5058904.10958904
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 4.942864879501761
Current ratio: 2.0678879310344827
Quick ratio: 1.8922413793103448
Retained earnings: -59513698.63013699
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLARI.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.511363636363637
Shares outstanding: 357286663
Market cap (USD): 10901303297.21591
Buyback yield (%): 0.02676910951488795
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLARI.PA — annual report dated 2022-12-31
Total revenue: 4721591489.361702
Gross profit: 4347191489.361702
Operating income: 355815957.4468085
Net income: 33338297.872340426
Capital expenditures: 102026595.74468085
Operating cash flow: 916703191.4893618
Depreciation & amortization: 696682978.7234043
Net tangible assets: -2079519148.9361703
Owner earnings: 627994680.8510638
Return on net tangible assets (%): -30.199033328081164
Capex to operating income (%): 28.673979794718164
Buffett classification: The Good
Stock price: 10.531914893617023
P/E ratio: 112.87057130959221
Shares outstanding: 357286663
Book value: 4114762765.957447
P/B ratio: 0.9144908081875406
Market cap (USD): 3762912727.340426
Debt to equity: 2.138264737994512
Current ratio: 0.6473983717057458
Quick ratio: 0.6377357547883511
Effective tax rate (%): 20.992491585397428
Interest coverage ratio: 1.707335375191424
COGS to revenue (%): 7.929529711402755
SG&A to revenue (%): 10.31540032480934
Free cash flow (dilution-adjusted): 254787234.04255322
Buyback yield (%): 0.1830293323709634
Inventory turnover: 12.295566502463053
Receivables turnover: 10.07860698325037
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8805249635248216
FCF margin (%): 5.396215124002546
Rule of 40 score: 5.396215124002546
Financial ratios for CLARI.PA — annual report dated 2023-12-31
Total revenue: 5550647777.777778
Gross profit: 5102540000
Operating income: 351994444.4444444
Net income: -103435555.55555555
Capital expenditures: 63680000
Operating cash flow: 881294444.4444444
Depreciation & amortization: 833675555.5555556
Net tangible assets: -2274185555.5555553
Owner earnings: 666560000
Capex to operating income (%): 18.09119462112723
Buffett classification: The Great
Stock price: 2.6666666666666665
Shares outstanding: 357286663
Book value: 4374966666.666668
P/B ratio: 0.2177763871724736
Market cap (USD): 952764434.6666666
Debt to equity: 2.1726976967443554
Current ratio: 0.7379226853388748
Quick ratio: 0.7295652615648882
Interest coverage ratio: 1.1400219515267107
COGS to revenue (%): 8.073071751585351
Free cash flow (dilution-adjusted): 343390000
Buyback yield (%): 0.05749351653427563
Inventory turnover: 14.252288228434109
Receivables turnover: 8.839142835910158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.685828023412176
FCF margin (%): 6.186485140973536
Revenue growth (%): 17.55883138734125
Rule of 40 score: 23.74531652831479
Financial ratios for CLARI.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -1961891666.6666667
Buffett classification: The Gruesome
Stock price: 2.1770833333333335
Shares outstanding: 357286663
Book value: 4188356250
P/B ratio: 0.18571553917830733
Market cap (USD): 777842839.2395834
Debt to equity: 1.9850182375643588
Current ratio: 0.5640861909398364
Quick ratio: 0.5564345603236804
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLARI.PA — annual report dated 2024-12-31
Total revenue: 5501830208.333334
Gross profit: 5044322916.666667
Operating income: 299247916.6666667
Net income: -53850000
Capital expenditures: 320864583.3333334
Operating cash flow: 945972916.6666667
Depreciation & amortization: 802113541.6666667
Net tangible assets: -1961891666.6666667
Owner earnings: 427398958.3333334
Capex to operating income (%): 107.22366488210027
Buffett classification: The Gruesome
Stock price: 2.1770833333333335
Shares outstanding: 357286663
Book value: 4188356250
P/B ratio: 0.18571553917830733
Market cap (USD): 777842839.2395834
Debt to equity: 1.9850182375643588
Current ratio: 0.5640861909398364
Quick ratio: 0.5564345603236804
Interest coverage ratio: 0.880270382899446
COGS to revenue (%): 8.315547269592297
Free cash flow (dilution-adjusted): 625108333.3333334
Buyback yield (%): 0
Inventory turnover: 19.74851618705036
Receivables turnover: 11.549620607465396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5301137863361807
FCF margin (%): 11.361825241108214
Revenue growth (%): -0.8794931942878205
Rule of 40 score: 10.482332046820394
Financial ratios for CLARI.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -2202236470.5882354
Buffett classification: The Gruesome
Stock price: 6.11764705882353
Shares outstanding: 357286663
Book value: 4608429411.764706
P/B ratio: 0.47429471252806565
Market cap (USD): 2185753703.0588236
Debt to equity: 2.0952063545957347
Current ratio: 0.7013367948286654
Quick ratio: 0.6888162382909827
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 88.45
Shares outstanding: 1275927307
Market cap (USD): 112855770304.15001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVS — annual report dated 2022-12-31
Total revenue: 322467000000
Gross profit: 54502000000
Operating income: 16290000000
Net income: 4327000000
Capital expenditures: 2727000000
Operating cash flow: 16177000000
Depreciation & amortization: 4224000000
Net tangible assets: -31484000000
Owner earnings: 5824000000
Return on net tangible assets (%): -18.498284843094908
Capex to operating income (%): 16.740331491712706
Buffett classification: The Great
Stock price: 81.7
P/E ratio: 24.09134758074879
Shares outstanding: 1275927307
Book value: 71769000000
P/B ratio: 1.4524831192004906
Market cap (USD): 104243260981.90001
Debt to equity: 0.9855508645794145
Current ratio: 0.9454343786462309
Quick ratio: 0.6704455424151193
Effective tax rate (%): 25.85675119945168
Interest coverage ratio: 7.122868386532575
COGS to revenue (%): 83.0984255753302
Free cash flow (dilution-adjusted): 13003000000
Buyback yield (%): 3.3575311890978856
Retained earnings: 56398000000
Inventory turnover: 14.036930330015714
Receivables turnover: 11.822371315442147
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.25469928361892
FCF margin (%): 4.032350597115364
Rule of 40 score: 4.032350597115364
Financial ratios for CVS — annual report dated 2023-12-31
Total revenue: 357776000000
Gross profit: 54431000000
Operating income: 14599000000
Net income: 8368000000
Capital expenditures: 3031000000
Operating cash flow: 13426000000
Depreciation & amortization: 4366000000
Net tangible assets: -44045000000
Owner earnings: 9703000000
Return on net tangible assets (%): -22.029742309002156
Capex to operating income (%): 20.761696006575793
Buffett classification: The Great
Stock price: 71.46
P/E ratio: 10.896004464414435
Shares outstanding: 1275927307
Book value: 76636000000
P/B ratio: 1.1897511007649146
Market cap (USD): 91177765358.21999
Debt to equity: 1.0358708700871653
Current ratio: 0.8569119448408239
Quick ratio: 0.6292919471138668
Effective tax rate (%): 25.10516423520988
Interest coverage ratio: 5.492475545522949
COGS to revenue (%): 84.78629086355708
Free cash flow (dilution-adjusted): 9807000000
Buyback yield (%): 2.2066783410354898
Retained earnings: 61604000000
Inventory turnover: 16.829126213592232
Receivables turnover: 10.1563005649076
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.560505221679499
FCF margin (%): 2.7411005768972765
Revenue growth (%): 10.949647560835682
Rule of 40 score: 13.690748137732959
Financial ratios for CVS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 58.64
Shares outstanding: 1275927307
Market cap (USD): 74820377282.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 42.33
Shares outstanding: 1275927307
Market cap (USD): 54010002905.31
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVS — annual report dated 2024-12-31
Total revenue: 372809000000
Gross profit: 51401000000
Operating income: 9695000000
Net income: 4614000000
Capital expenditures: 2781000000
Operating cash flow: 9107000000
Depreciation & amortization: 4597000000
Net tangible assets: -43035000000
Owner earnings: 6430000000
Return on net tangible assets (%): -14.941326827001278
Capex to operating income (%): 28.684889118102113
Buffett classification: The Good
Stock price: 42.33
P/E ratio: 11.705678999850456
Shares outstanding: 1275927307
Book value: 75730000000
P/B ratio: 0.7131916401070909
Market cap (USD): 54010002905.31
Debt to equity: 1.0949425590915094
Current ratio: 0.811320308714203
Quick ratio: 0.5973123426585825
Effective tax rate (%): 25.406636304489265
Interest coverage ratio: 3.277552400270453
COGS to revenue (%): 86.21251096405935
Free cash flow (dilution-adjusted): 5786000000
Buyback yield (%): 5.597111344911247
Retained earnings: 62837000000
Inventory turnover: 17.750483238526538
Receivables turnover: 10.22262743700129
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.75009193029904
FCF margin (%): 1.5520011587703086
Revenue growth (%): 4.201791064800322
Rule of 40 score: 5.75379222357063
Financial ratios for CVS — quarterly report dated 2025-03-31
Total revenue: 94588000000
Gross profit: 14396000000
Operating income: 3374000000
Net income: 1782000000
Capital expenditures: 743000000
Operating cash flow: 4556000000
Depreciation & amortization: 1154000000
Net tangible assets: -40844000000
Owner earnings: 2193000000
Return on net tangible assets (%): -5.36920967583978
Capex to operating income (%): 22.021339656194428
Buffett classification: The Great
Stock price: 64.69
P/E ratio: 11.579648918326317
Shares outstanding: 1275927307
Book value: 77110000000
P/B ratio: 1.0704154777568409
Market cap (USD): 82539737489.83
Debt to equity: 1.0532097004279601
Current ratio: 0.822731309225391
Quick ratio: 0.6273085959015748
Effective tax rate (%): 31.9067634696217
Interest coverage ratio: 4.298089171974523
COGS to revenue (%): 84.78031039878209
Free cash flow (dilution-adjusted): 3687000000
Buyback yield (%): 0
Retained earnings: 63768000000
Inventory turnover: 4.612712108139201
Receivables turnover: 2.3870788643533123
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.024918379105051
FCF margin (%): 3.8979574576056155
Rule of 40 score: 3.8979574576056155
Financial ratios for CVS — quarterly report dated 2025-06-30
Total revenue: 98915000000
Gross profit: 13593000000
Operating income: 2381000000
Net income: 1021000000
Capital expenditures: 607000000
Operating cash flow: 1897000000
Depreciation & amortization: 1171000000
Net tangible assets: -40048000000
Owner earnings: 1585000000
Return on net tangible assets (%): -3.957750699161007
Capex to operating income (%): 25.493490130197394
Buffett classification: The Good
Stock price: 66.55
P/E ratio: 30.293600528308954
Shares outstanding: 1275927307
Book value: 77551000000
P/B ratio: 1.0949305912348004
Market cap (USD): 84912962280.84999
Debt to equity: 1.066704491238024
Current ratio: 0.8033920265075083
Quick ratio: 0.6181049680338141
Effective tax rate (%): 38.49423193685489
Interest coverage ratio: 3.1205766710353866
COGS to revenue (%): 86.25789819542031
Free cash flow (dilution-adjusted): 1154000000
Buyback yield (%): 0
Retained earnings: 63936000000
Inventory turnover: 4.890353642460021
Receivables turnover: 2.4332734742072764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4502287109957912
FCF margin (%): 1.166658241924885
Revenue growth (%): 4.574576056159343
Rule of 40 score: 5.741234298084228
Financial ratios for CVS — quarterly report dated 2025-09-30
Total revenue: 102871000000
Gross profit: 13806000000
Operating income: 2518000000
Net income: -3975000000
Capital expenditures: 698000000
Operating cash flow: 796000000
Depreciation & amortization: 1134000000
Net tangible assets: -38534000000
Owner earnings: -3539000000
Capex to operating income (%): 27.720413026211276
Buffett classification: The Good
Stock price: 73.52
Shares outstanding: 1275927307
Book value: 73110000000
P/B ratio: 1.2830826919797564
Market cap (USD): 93806175610.64
Debt to equity: 1.1182054438517304
Current ratio: 0.8318571659744323
Quick ratio: 0.6272938130427747
Interest coverage ratio: 3.211734693877551
COGS to revenue (%): 86.57930806544118
Free cash flow (dilution-adjusted): -40000000
Buyback yield (%): 0
Retained earnings: 59107000000
Inventory turnover: 4.697025630207784
Receivables turnover: 2.345600474268646
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5482807811500812
FCF margin (%): -0.03888365039709928
Revenue growth (%): 3.99939341859172
Rule of 40 score: 3.960509768194621
Financial ratios for CVS — quarterly report dated 2025-12-31
Total revenue: 105693000000
Gross profit: 13567000000
Operating income: 2112000000
Net income: 2943000000
Capital expenditures: 784000000
Operating cash flow: 3390000000
Depreciation & amortization: 1147000000
Net tangible assets: -35772000000
Owner earnings: 3306000000
Return on net tangible assets (%): -9.241865145924187
Capex to operating income (%): 37.121212121212125
Buffett classification: The Good
Stock price: 78.03
P/E ratio: 56.21716982789949
Shares outstanding: 1275927307
Book value: 75382000000
P/B ratio: 1.3207477616036984
Market cap (USD): 99560607765.21
Debt to equity: 1.0605980207476586
Current ratio: 0.8423984124836513
Quick ratio: 0.6254002615793983
Effective tax rate (%): -115.87887740029541
Interest coverage ratio: 2.6836086404066073
COGS to revenue (%): 87.16376675844191
Free cash flow (dilution-adjusted): 2471000000
Buyback yield (%): 0
Retained earnings: 61196000000
Inventory turnover: 4.78676088537878
Receivables turnover: 2.657004952361799
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2811957827305485
FCF margin (%): 2.3379031723955226
Revenue growth (%): 2.743241535515354
Rule of 40 score: 5.081144707910877
Financial ratios for CVS — annual report dated 2025-12-31
Total revenue: 402067000000
Gross profit: 55362000000
Operating income: 10385000000
Net income: 1768000000
Capital expenditures: 2832000000
Operating cash flow: 10639000000
Depreciation & amortization: 4606000000
Net tangible assets: -35772000000
Owner earnings: 3542000000
Return on net tangible assets (%): -9.901599015990161
Capex to operating income (%): 27.270101107366397
Buffett classification: The Good
Stock price: 78.03
P/E ratio: 56.312560953173076
Shares outstanding: 1275927307
Book value: 75382000000
P/B ratio: 1.3207477616036984
Market cap (USD): 99560607765.21
Debt to equity: 1.0605980207476586
Current ratio: 0.8423984124836513
Quick ratio: 0.6254002615793983
Effective tax rate (%): 19.101123595505616
Interest coverage ratio: 3.329592818210965
COGS to revenue (%): 86.2306531001052
Free cash flow (dilution-adjusted): 7272000000
Buyback yield (%): 0
Retained earnings: 61196000000
Inventory turnover: 18.01439260105996
Receivables turnover: 10.107519042710978
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.299819225216262
FCF margin (%): 1.8086537815836665
Revenue growth (%): 7.847986502471775
Rule of 40 score: 9.656640284055442
Financial ratios for CWK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.24
Shares outstanding: 234300505
Market cap (USD): 5210843231.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWK — annual report dated 2022-12-31
Total revenue: 10105700000
Gross profit: 1952200000
Operating income: 544000000
Net income: 196400000
Capital expenditures: 50700000
Operating cash flow: 49100000
Depreciation & amortization: 249100000
Net tangible assets: -1281600000
Owner earnings: 394800000
Return on net tangible assets (%): -30.80524344569288
Capex to operating income (%): 9.319852941176471
Buffett classification: The Great
Stock price: 12.46
P/E ratio: 14.86448214002037
Shares outstanding: 234300505
Book value: 1662100000
P/B ratio: 1.7564432298297337
Market cap (USD): 2919384292.3
Debt to equity: 2.163588231755009
Current ratio: 1.1574631860776439
Quick ratio: 1.1574631860776439
Effective tax rate (%): 41.89349112426036
Interest coverage ratio: 2.817193164163646
COGS to revenue (%): 80.68218925952681
SG&A to revenue (%): 12.481075036860386
Free cash flow (dilution-adjusted): -41900000
Buyback yield (%): 0.9317033071576479
Retained earnings: -1081800000
Receivables turnover: 5.38683368869936
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.786108762524961
FCF margin (%): -0.4146174930979546
Rule of 40 score: -0.4146174930979546
Financial ratios for CWK — annual report dated 2023-12-31
Total revenue: 9493700000
Gross profit: 1652100000
Operating income: 243700000
Net income: -35400000
Capital expenditures: 51000000
Operating cash flow: 152200000
Depreciation & amortization: 243400000
Net tangible assets: -1219400000
Owner earnings: 157000000
Capex to operating income (%): 20.927369716864998
Buffett classification: The Great
Stock price: 10.8
Shares outstanding: 234300505
Book value: 1678000000
P/B ratio: 1.5080127854588796
Market cap (USD): 2530445454
Debt to equity: 2.1252681764004766
Current ratio: 1.1693642583013515
Quick ratio: 1.1693642583013515
Interest coverage ratio: 0.8669512628957666
COGS to revenue (%): 82.59793336633767
SG&A to revenue (%): 13.301452542212203
Free cash flow (dilution-adjusted): 47100000
Buyback yield (%): 0.3201017428451552
Retained earnings: -1117200000
Receivables turnover: 5.142570824982395
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.532435649456926
FCF margin (%): 0.4961184785699991
Revenue growth (%): -6.055988204676568
Rule of 40 score: -5.5598697261065695
Financial ratios for CWK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.63
Shares outstanding: 234300505
Market cap (USD): 3193515883.15
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.08
Shares outstanding: 234300505
Market cap (USD): 3064650605.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWK — annual report dated 2024-12-31
Total revenue: 9446500000
Gross profit: 1726300000
Operating income: 380000000
Net income: 131300000
Capital expenditures: 41000000
Operating cash flow: 208000000
Depreciation & amortization: 208700000
Net tangible assets: -936000000
Owner earnings: 299000000
Return on net tangible assets (%): -31.944444444444443
Capex to operating income (%): 10.789473684210527
Buffett classification: The Great
Stock price: 13.08
P/E ratio: 23.34082715460777
Shares outstanding: 234300505
Book value: 1755400000
P/B ratio: 1.7458417485473396
Market cap (USD): 3064650605.4
Debt to equity: 1.887376096616156
Current ratio: 1.1547276707154814
Quick ratio: 1.1547276707154814
Effective tax rate (%): 25.312855517633675
Interest coverage ratio: 1.6528925619834711
COGS to revenue (%): 81.72550680146085
Free cash flow (dilution-adjusted): 131400000
Buyback yield (%): 0.3393535296217751
Retained earnings: -985900000
Receivables turnover: 5.505274200128213
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.280669821623589
FCF margin (%): 1.3909913724659928
Revenue growth (%): -0.49717180867312005
Rule of 40 score: 0.8938195637928728
Financial ratios for CWK — quarterly report dated 2025-03-31
Total revenue: 2284600000
Gross profit: 384300000
Operating income: 51800000
Net income: 1900000
Capital expenditures: 4600000
Operating cash flow: -162000000
Depreciation & amortization: 48400000
Net tangible assets: -926800000
Owner earnings: 45700000
Return on net tangible assets (%): -4.930945187742771
Capex to operating income (%): 8.880308880308881
Buffett classification: The Great
Stock price: 10.22
P/E ratio: 315.0725211973684
Shares outstanding: 234300505
Book value: 1776900000
P/B ratio: 1.3476004058191233
Market cap (USD): 2394551161.1000004
Debt to equity: 1.8424221959592548
Current ratio: 1.1822803195352214
Quick ratio: 1.1822803195352214
Effective tax rate (%): 62
Interest coverage ratio: 0.9904397705544933
COGS to revenue (%): 83.17867460386938
Free cash flow (dilution-adjusted): -182600000
Buyback yield (%): 0.42596709419707535
Retained earnings: -984000000
Receivables turnover: 1.31905311778291
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.995330784159253
FCF margin (%): -7.992646415127375
Rule of 40 score: -7.992646415127375
Financial ratios for CWK — quarterly report dated 2025-06-30
Total revenue: 2483900000
Gross profit: 467300000
Operating income: 122800000
Net income: 57300000
Capital expenditures: 9300000
Operating cash flow: 9600000
Depreciation & amortization: 47900000
Net tangible assets: -830700000
Owner earnings: 95900000
Return on net tangible assets (%): -11.544480558565064
Capex to operating income (%): 7.5732899022801305
Buffett classification: The Great
Stock price: 11.07
P/E ratio: 43.81261132347973
Shares outstanding: 234300505
Book value: 1904100000
P/B ratio: 1.3621693137702853
Market cap (USD): 2593706590.35
Debt to equity: 1.702536631479439
Current ratio: 1.133992689744141
Quick ratio: 1.133992689744141
Effective tax rate (%): 24.803149606299215
COGS to revenue (%): 81.18684327066306
Free cash flow (dilution-adjusted): -13800000
Buyback yield (%): 0.007710972426260891
Retained earnings: -926700000
Receivables turnover: 1.3884292901062045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3480372473661064
FCF margin (%): -0.5555779218164982
Revenue growth (%): 8.723627768537161
Rule of 40 score: 8.168049846720663
Financial ratios for CWK — quarterly report dated 2025-09-30
Total revenue: 2605900000
Gross profit: 453900000
Operating income: 107500000
Net income: 51400000
Capital expenditures: 10500000
Operating cash flow: 235500000
Depreciation & amortization: 47000000
Net tangible assets: -762100000
Owner earnings: 87900000
Return on net tangible assets (%): -11.533919433145257
Capex to operating income (%): 9.767441860465116
Buffett classification: The Great
Stock price: 15.92
P/E ratio: 33.7257146437613
Shares outstanding: 234300505
Book value: 1958000000
P/B ratio: 1.9050378138917263
Market cap (USD): 3730064039.6
Debt to equity: 1.5883043922369766
Current ratio: 1.0661186704441163
Quick ratio: 1.0661186704441163
Effective tax rate (%): -13.968957871396896
COGS to revenue (%): 82.58183353160136
Free cash flow (dilution-adjusted): 211000000
Buyback yield (%): 0.013404595596530787
Retained earnings: -875300000
Receivables turnover: 1.4247676325861127
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.073168379843018
FCF margin (%): 8.097010629724855
Revenue growth (%): 4.9116309030154195
Rule of 40 score: 13.008641532740274
Financial ratios for CWK — quarterly report dated 2025-12-31
Total revenue: 2913800000
Gross profit: 574500000
Operating income: 176500000
Net income: -22400000
Capital expenditures: 23000000
Operating cash flow: 257300000
Depreciation & amortization: 47400000
Net tangible assets: -761500000
Owner earnings: 2000000
Capex to operating income (%): 13.031161473087819
Buffett classification: The Great
Stock price: 16.19
P/E ratio: 43.00822194954649
Shares outstanding: 234300505
Book value: 1955800000
P/B ratio: 1.939526115119133
Market cap (USD): 3793325175.9500003
Debt to equity: 1.532058492688414
Current ratio: 1.0969596419476813
Quick ratio: 1.0969596419476813
COGS to revenue (%): 80.28347861898551
Free cash flow (dilution-adjusted): 220200000
Buyback yield (%): 0.007908628606427551
Retained earnings: -897700000
Receivables turnover: 1.5588487053284827
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4711296412838264
FCF margin (%): 7.557141876587274
Revenue growth (%): 11.815495606124564
Rule of 40 score: 19.372637482711838
Financial ratios for CWK — annual report dated 2025-12-31
Total revenue: 10288200000
Gross profit: 1880000000
Operating income: 458600000
Net income: 88200000
Capital expenditures: 47400000
Operating cash flow: 340400000
Depreciation & amortization: 190700000
Net tangible assets: -761500000
Owner earnings: 231500000
Return on net tangible assets (%): -30.400525279054495
Capex to operating income (%): 10.335804622764936
Buffett classification: The Great
Stock price: 16.19
P/E ratio: 43.00822194954649
Shares outstanding: 234300505
Book value: 1955800000
P/B ratio: 1.939526115119133
Market cap (USD): 3793325175.9500003
Debt to equity: 1.532058492688414
Current ratio: 1.0969596419476813
Quick ratio: 1.0969596419476813
Effective tax rate (%): 22.76707530647986
Interest coverage ratio: 2.1211840888066607
COGS to revenue (%): 81.72663828463676
Free cash flow (dilution-adjusted): 234800000
Buyback yield (%): 0.29525546797329527
Retained earnings: -897700000
Receivables turnover: 5.504065910549968
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.01903713027061
FCF margin (%): 2.2822262397698334
Revenue growth (%): 8.91017837294236
Rule of 40 score: 11.192404612712194
Financial ratios for DCBO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 67.36
Shares outstanding: 25382651
Market cap (USD): 1709775371.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCBO — annual report dated 2022-12-31
Total revenue: 105082352.94117646
Gross profit: 84363235.29411764
Operating income: -5093382.352941176
Net income: 5160294.117647058
Capital expenditures: 794852.9411764705
Operating cash flow: 1682352.9411764704
Depreciation & amortization: 1715441.1764705882
Net tangible assets: 136087500
Owner earnings: 6080882.352941176
Return on net tangible assets (%): 4.468362158861891
Buffett classification: The Gruesome
Stock price: 33.14
P/E ratio: 163.0102926233115
Shares outstanding: 25382651
Book value: 141331617.64705884
P/B ratio: 5.9518249924843
Market cap (USD): 841181054.14
Debt to equity: 0.01595122027355354
Current ratio: 3.1244517673834196
Quick ratio: 3.1244517673834196
Effective tax rate (%): 9.817527627859162
Interest coverage ratio: -18.42287234042553
COGS to revenue (%): 19.717028660994178
R&D to revenue (%): 17.337942230183607
SG&A to revenue (%): 66.1595947156292
Free cash flow (dilution-adjusted): -2577941.176470588
Buyback yield (%): 0
Retained earnings: -55051470.58823529
Receivables turnover: 3.764606711975133
Capitalized R&D asset: 18219117.647058822
ROCI (R&D-adjusted, %): 4.280369800150241
FCF margin (%): -2.4532579489476043
Rule of 40 score: -2.4532579489476043
Financial ratios for DCBO — annual report dated 2023-12-31
Total revenue: 136999242.4242424
Gross profit: 110864393.93939394
Operating income: 515151.51515151514
Net income: 2151515.1515151514
Capital expenditures: 481060.606060606
Operating cash flow: 12093939.393939393
Depreciation & amortization: 2379545.4545454546
Net tangible assets: 25809848.484848484
Owner earnings: 4049999.9999999995
Return on net tangible assets (%): 15.691684522586513
Capex to operating income (%): 93.38235294117646
Buffett classification: The Gruesome
Stock price: 48.38
P/E ratio: 570.7664454583099
Shares outstanding: 25382651
Book value: 38424999.999999985
P/B ratio: 31.958689795185443
Market cap (USD): 1228012655.38
Debt to equity: 0.04158041048086593
Current ratio: 1.2632933275046696
Quick ratio: 1.2632933275046696
Effective tax rate (%): 41.39496491952126
Interest coverage ratio: 2.2972972972972974
COGS to revenue (%): 19.076637229801097
R&D to revenue (%): 19.619108709957477
SG&A to revenue (%): 59.191324880142005
Free cash flow (dilution-adjusted): 7030303.030303029
Buyback yield (%): 9.836538643533812
Retained earnings: -155143181.8181818
Receivables turnover: 4.231240787103114
Capitalized R&D asset: 39084839.12655971
ROCI (R&D-adjusted, %): 14.925908380139472
Rosenberg metric: 1.454579698021461
FCF margin (%): 5.131636427982902
Revenue growth (%): 30.3732154731371
Rule of 40 score: 35.504851901120006
Financial ratios for DCBO — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 519259.2592592592
Buffett classification: The Gruesome
Stock price: 44.2
Shares outstanding: 25382651
Market cap (USD): 1121913174.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCBO — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 484615.3846153846
Buffett classification: The Gruesome
Stock price: 44.77
Shares outstanding: 25382651
Market cap (USD): 1136381285.27
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCBO — annual report dated 2024-12-31
Total revenue: 151700000
Gross profit: 122822377.62237763
Operating income: 13221678.321678322
Net income: 18696503.4965035
Capital expenditures: 870629.3706293707
Operating cash flow: 20453846.153846156
Depreciation & amortization: 2366433.5664335666
Net tangible assets: 29535664.335664336
Owner earnings: 20192307.692307696
Return on net tangible assets (%): 68.36584903873474
Capex to operating income (%): 6.584862749246312
Buffett classification: The Great
Stock price: 44.77
P/E ratio: 60.78041733752618
Shares outstanding: 25382651
Book value: 40392307.692307696
P/B ratio: 28.13360637689964
Market cap (USD): 1136381285.27
Debt to equity: 0.025882515884420282
Current ratio: 1.1993670393928555
Quick ratio: 1.1993670393928555
Effective tax rate (%): -12.748281533336147
Interest coverage ratio: 102.19999999999999
COGS to revenue (%): 19.036006840884887
R&D to revenue (%): 20.240537313708046
SG&A to revenue (%): 50.4478382527163
Free cash flow (dilution-adjusted): 14457342.65734266
Buyback yield (%): 0.6783894639077286
Retained earnings: -143613986.01398602
Receivables turnover: 4.75705012938029
Capitalized R&D asset: 54725484.23145483
ROCI (R&D-adjusted, %): 19.009039599321383
Rosenberg metric: 0.4448980653777863
FCF margin (%): 9.530219286316848
Revenue growth (%): 10.730539319505208
Rule of 40 score: 20.260758605822055
Financial ratios for DCBO — quarterly report dated 2025-03-31
Total revenue: 40067132.86713287
Gross profit: 32098601.3986014
Operating income: 1280419.5804195805
Net income: 1030769.2307692309
Capital expenditures: 208391.6083916084
Operating cash flow: 5555944.055944056
Depreciation & amortization: 558041.958041958
Net tangible assets: 25782517.482517485
Owner earnings: 1380419.5804195807
Return on net tangible assets (%): 5.3540915131953675
Capex to operating income (%): 16.275259421081376
Buffett classification: The Great
Stock price: 28.71
P/E ratio: 176.74564986436565
Shares outstanding: 25382651
Book value: 36666433.566433564
P/B ratio: 19.874742082282154
Market cap (USD): 728735910.21
Debt to equity: 0.02141780939484676
Current ratio: 1.1508188324345858
Quick ratio: 1.1508188324345858
Effective tax rate (%): 37.462876537972
Interest coverage ratio: 59.06451612903226
COGS to revenue (%): 19.887950293214185
R&D to revenue (%): 23.39255794470818
SG&A to revenue (%): 52.131038815973184
Free cash flow (dilution-adjusted): 4795804.195804196
Buyback yield (%): 0.9027031035736939
Retained earnings: -146001398.60139862
Receivables turnover: 1.1228125183719064
Capitalized R&D asset: 9372727.272727273
ROCI (R&D-adjusted, %): 15.26922895097623
FCF margin (%): 11.969421949176208
Rule of 40 score: 11.969421949176208
Financial ratios for DCBO — quarterly report dated 2025-06-30
Total revenue: 44329927.00729927
Gross profit: 35874452.55474452
Operating income: 3709489.05109489
Net income: 2245255.4744525547
Capital expenditures: 210218.97810218975
Operating cash flow: 4557664.233576642
Depreciation & amortization: 618248.1751824816
Net tangible assets: 13724087.591240875
Owner earnings: 2653284.6715328465
Return on net tangible assets (%): 19.33304967556643
Capex to operating income (%): 5.667060212514758
Buffett classification: The Great
Stock price: 28.94
P/E ratio: 224.22722233111784
Shares outstanding: 25382651
Book value: 25316788.32116787
P/B ratio: 29.01528861485989
Market cap (USD): 734573919.94
Debt to equity: 0.03961480798062508
Current ratio: 1.0377145472576093
Quick ratio: 1.0377145472576093
Effective tax rate (%): 34.31560965193252
Interest coverage ratio: 195.46153846153845
COGS to revenue (%): 19.07396430218007
R&D to revenue (%): 20.909899229401304
SG&A to revenue (%): 50.25357307514984
Free cash flow (dilution-adjusted): 3082481.7518248167
Buyback yield (%): 3.399160028405708
Retained earnings: -160425547.44525546
Receivables turnover: 1.2368790859656627
Capitalized R&D asset: 15549070.338420704
ROCI (R&D-adjusted, %): 15.083252613418368
Rosenberg metric: 0.4028551185021755
FCF margin (%): 6.953500625699795
Revenue growth (%): 10.639129468790042
Rule of 40 score: 17.592630094489838
Financial ratios for DCBO — quarterly report dated 2025-09-30
Total revenue: 44332374.10071943
Gross profit: 35604316.54676259
Operating income: 5858992.805755396
Net income: 4394964.028776979
Capital expenditures: 160431.654676259
Operating cash flow: 3807913.6690647486
Depreciation & amortization: 534532.3741007195
Net tangible assets: 21229496.4028777
Owner earnings: 4769064.74820144
Return on net tangible assets (%): 22.464332915381753
Capex to operating income (%): 2.7382121807465616
Buffett classification: The Great
Stock price: 27.33
P/E ratio: 90.43265162877915
Shares outstanding: 25382651
Book value: 32544604.316546768
P/B ratio: 21.315602582923265
Market cap (USD): 693707851.8299999
Debt to equity: 0.06421734420938612
Current ratio: 1.1342220900650875
Quick ratio: 1.1342220900650875
Effective tax rate (%): 25.915595440213433
Interest coverage ratio: 180.9777777777778
COGS to revenue (%): 19.687773847002692
R&D to revenue (%): 19.31939891597157
SG&A to revenue (%): 46.57102982700983
Free cash flow (dilution-adjusted): 2262589.928057554
Buyback yield (%): 0.3520856851659239
Retained earnings: -151483453.23741007
Receivables turnover: 1.3136498326547144
Capitalized R&D asset: 17868208.05545345
ROCI (R&D-adjusted, %): 9.666734877456726
Rosenberg metric: -0.029142950699680203
FCF margin (%): 5.103696731686735
Revenue growth (%): 0.005520183734477759
Rule of 40 score: 5.1092169154212135
Financial ratios for DCBO — quarterly report dated 2025-12-31
Total revenue: 46012408.759124085
Gross profit: 36713138.68613138
Operating income: 6877372.262773722
Net income: 19600729.9270073
Capital expenditures: 125547.44525547445
Operating cash flow: 6343795.6204379555
Depreciation & amortization: 582481.7518248175
Net tangible assets: 42716058.39416058
Owner earnings: 20057664.233576644
Return on net tangible assets (%): 46.95579364672511
Capex to operating income (%): 1.825514752706432
Buffett classification: The Great
Stock price: 22.2
P/E ratio: 20.662242053915808
Shares outstanding: 25382651
Book value: 54081021.897810206
P/B ratio: 10.419456445641174
Market cap (USD): 563494852.1999999
Debt to equity: 0.03455210484404314
Current ratio: 1.2239517282045895
Quick ratio: 1.2239517282045895
Effective tax rate (%): -193.1870291516541
Interest coverage ratio: 214.13636363636363
COGS to revenue (%): 20.210352650030934
R&D to revenue (%): 19.215698716626743
SG&A to revenue (%): 44.361248155844976
Free cash flow (dilution-adjusted): 5086131.386861313
Buyback yield (%): 0.00518142804286133
Retained earnings: -134332846.71532845
Receivables turnover: 1.1238545195221965
Capitalized R&D asset: 17638870.34605892
ROCI (R&D-adjusted, %): 8.74013088458057
Rosenberg metric: 0.12946348372302516
FCF margin (%): 11.053825531037326
Revenue growth (%): 3.7896338567110304
Rule of 40 score: 14.843459387748357
Financial ratios for DCBO — annual report dated 2025-12-31
Total revenue: 177143795.62043795
Gross profit: 142216058.39416057
Operating income: 17867883.21167883
Net income: 27381021.897810217
Capital expenditures: 716058.3941605838
Operating cash flow: 20564233.576642334
Depreciation & amortization: 2325547.445255474
Net tangible assets: 42716058.39416058
Owner earnings: 28990510.948905107
Return on net tangible assets (%): 67.86794484031373
Capex to operating income (%): 4.007516646921851
Buffett classification: The Great
Stock price: 22.2
P/E ratio: 20.579759743921947
Shares outstanding: 25382651
Book value: 54081021.897810206
P/B ratio: 10.419456445641174
Market cap (USD): 563494852.1999999
Debt to equity: 0.03455210484404314
Current ratio: 1.2239517282045895
Quick ratio: 1.2239517282045895
Effective tax rate (%): -53.45469421149519
Interest coverage ratio: 167.66438356164383
COGS to revenue (%): 19.717166556099006
R&D to revenue (%): 20.65211568810855
SG&A to revenue (%): 48.23126084215471
Free cash flow (dilution-adjusted): 15470072.99270073
Buyback yield (%): 6.09465473541564
Retained earnings: -134332846.71532845
Receivables turnover: 4.326742734890355
Capitalized R&D asset: 66025971.32611914
ROCI (R&D-adjusted, %): 18.231666420104663
Rosenberg metric: 0.6316152752038261
FCF margin (%): 8.733059455183014
Revenue growth (%): 16.77244272935923
Rule of 40 score: 25.505502184542244